Brief: MEI Pharma Inc Says Daniel Gold, Chief Executive Officer, Notified Drazba That His Employment Will Continue Beyond June 30, 2022
July 7 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA INC - ON JUNE 30, 2022, DANIEL GOLD, CHIEF
EXECUTIVE
OFFICER, NOTIFIED DRAZBA THAT HIS EMPLOYMENT WILL CONTINUE
BEYOND JUNE 30, 2022
* MEI PHARMA INC - ON JULY 7, 2022, COMPANY AND DRAZBA
AGREED TO
TERMINATE RETIREMENT AGREEMENT PURSUANT TO LETTER AGREEMENT
Further company coverage: MEIP.O
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations